Evidence map›Paper›PMID 34485892›Full record

ReviewMaterials today. Bio2021

Paper-based plasmonic substrates as surface-enhanced Raman scattering spectroscopy platforms for cell culture applications.

J M Romo-Herrera, K Juarez-Moreno, L Guerrini, Y Kang, N Feliu, W J Parak, R A Alvarez-Puebla

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Paper-Based Sensors: Fantasy or Reality?Nanomaterials (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Surface-Enhanced Raman Spectroscopy at the Interface between Drug Discovery and Personalized Medicine.The journal of physical chemistry. C, Nanomaterials and interfaces · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J M Romo-HerreraCentro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México (CNyN-UNAM), Km 107 Carretera Tijuana-Ensenada, CP 22800 Ensenada, B.C., México.
K Juarez-MorenoCentro de Nanociencias y Nanotecnología, Universidad Nacional Autónoma de México (CNyN-UNAM), Km 107 Carretera Tijuana-Ensenada, CP 22800 Ensenada, B.C., México.
L GuerriniDepartment of Inorganic and Physical Chemistry, Universitat Rovira i Virgili. C/Marcel·lí Domingo s/n, 43007 Tarragona, Spain.
Y KangCHyN, Universität Hamburg, Luruper Chausse 149, 22761 Hamburg, Germany.
N FeliuCHyN, Universität Hamburg, Luruper Chausse 149, 22761 Hamburg, Germany.
W J ParakCHyN, Universität Hamburg, Luruper Chausse 149, 22761 Hamburg, Germany.
R A Alvarez-PueblaDepartment of Inorganic and Physical Chemistry, Universitat Rovira i Virgili. C/Marcel·lí Domingo s/n, 43007 Tarragona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The engineering of advanced materials capable of mimicking the cellular micro-environment while providing cells with physicochemical cues is central for cell culture applications. In this regard, paper meets key requirements in terms of biocompatibility, hydrophilicity, porosity, mechanical strength, ease of physicochemical modifications, cost, and ease of large-scale production, to be used as a scaffold material for biomedical applications. Most notably, paper has demonstrated the potential to become an attractive alternative to conventional biomaterials for creating two-dimensional (2D) and three-dimensional (3D) biomimetic cell culture models that mimic the features of

Indexed as

Cell culturePaper-based substratesPlasmonic nanoparticlesPlasmonic papersSERS

Identifiers

PMID34485892
PMCPMC8397899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.